Category: Ritonavir

COVID-19 Therapeutics for Nonhospitalized Patients

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint summarizes currently available therapeutics for nonhospitalized patients in the setting of the Omicron variant including principles for equitable allocation. Patients with mild or moderate COVID-19 […]

COVID-19 and emerging spinal cord complications: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and emerging spinal cord complications: A systematic review

Ritwick Mondal,a Shramana Deb,b Gourav Shome,c Upasana Ganguly,a Durjoy Lahiri,a,d,⁎ and Julián Benito-Leóne,f,g,⁎⁎ Mult Scler Relat Disord. 2021 Jun; 51: 102917.Published online 2021 Mar 21. doi: 10.1016/j.msard.2021.102917 PMCID: PMC7981271 PMID: 33845350 Abstract Background : Spinal cord complications associated with coronavirus infectious disease of 2019 (COVID-19) are being widely reported. The purpose of this systematic review was to summarize so far available pieces of evidence documenting de novo novel severe […]

Long COVID: The hunt for causes and cures

Posted on | Posted on John Murphy | Leave a Comment on Long COVID: The hunt for causes and cures

With so many treatment candidates, researchers work to gain more clarity by Shi En Kim September 11, 2023 | A version of this story appeared in Volume 101, Issue 30 Hannah Davis misses her old self. Like so many people around the world, she has seen her life upended by long COVID, which has made many once-routine […]